LRI Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$772K Buy
9,871
+649
+7% +$52.4K 0.06% 152
2026
Q1
$799K Buy
9,222
+876
+10% +$83.9K 0.07% 132
2025
Q4
$802K Sell
8,346
-686
-8% -$66.6K 0.06% 134
2025
Q3
$860K Sell
9,032
-2,165
-19% -$199K 0.07% 125
2025
Q2
$976K Buy
11,197
+309
+3% +$26.2K 0.08% 109
2025
Q1
$978K Sell
10,888
-242
-2% -$21.7K 0.09% 108
2024
Q4
$889K Buy
11,130
+515
+5% +$44.6K 0.09% 90
2024
Q3
$913K Buy
10,615
+839
+9% +$70.6K 0.09% 94
2024
Q2
$769K Buy
9,776
+6,025
+161% +$494K 0.09% 82
2024
Q1
$327K Buy
+3,751
New +$320K 0.08% 102

Other funds holding MDT

LRI Investments's MDT Position: Q2 2026 in Review

LRI Investments increased its Medtronic (MDT) stake by 7% in Q2 2026, buying an estimated $52.4K and bringing the position to 9,871 shares worth $772K. The position accounts for 0.06% of the portfolio, ranked #152.

LRI Investments first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $978K in Q1 2025. 926 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • LRI Investments held 9,871 shares of Medtronic worth $772K as of Q2 2026.
  • LRI Investments bought 649 Medtronic shares in Q2 2026, an estimated $52.4K.
  • Medtronic made up 0.06% of LRI Investments's portfolio in Q2 2026, its #152 holding.
  • LRI Investments first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Medtronic position peaked at $978K in Q1 2025.
  • 926 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.